| Date Filed | Type | Description |
| 06/08/2023 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 32,500 shares
@ $0 |
|
| 10/04/2022 |
4
| Nolet Chris (Director) has filed a Form 4 on POLARITYTE, INC.|
Txns:
| Granted 50,900 shares
@ $0 |
|
| 05/13/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Nolet Chris (Director) has filed a Form 4 on Viela Bio, Inc.|
Txns:
| Granted 7,358 options to buy
@ $48.96, valued at
$360.2k
|
|
| 05/15/2020 |
4
| Nolet Chris (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $19.4, valued at
$232.8k
|
|
| 04/07/2020 |
4
| Nolet Chris (Director) has filed a Form 4 on POLARITYTE, INC.|
Txns:
| Granted 230,894 options to buy
@ $0.9, valued at
$207.8k
|
|
| 04/06/2020 |
3
| Nolet Chris (Director) has filed a Form 3 on POLARITYTE, INC. |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/18/2019 |
4
| Nolet Chris (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 18,000 options to buy
@ $12.32, valued at
$221.8k
|
|
| 07/18/2019 |
3
| Nolet Chris (Director) has filed a Form 3 on Revance Therapeutics, Inc. |